Welcome to our dedicated page for Hanover Insuranc SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hanover Insurance Group, Inc. (NYSE: THG) is an SEC-reporting holding company for several property and casualty insurance subsidiaries. This page provides access to the company’s U.S. Securities and Exchange Commission filings, which document its regulatory and financial reporting as a public insurer. These filings are a primary source for understanding The Hanover’s capital structure, debt issuance, financial results, and other material events.
Among the key documents are current reports on Form 8-K, where The Hanover discloses significant developments. Recent 8-K filings describe the issuance of senior unsecured notes due 2035, the planned use of proceeds to repay existing debentures and notes and for general corporate purposes, and the call for redemption of 4.500% notes due 2026. Another 8-K furnishes the company’s quarterly financial results and references an accompanying financial supplement made available on its website.
Filings also include a Form 25 submitted by the New York Stock Exchange relating to the removal from listing and registration of a specific class of 7 5/8% senior debentures due 2025. The same filing identifies The Hanover’s common stock as listed on the New York Stock Exchange under the symbol THG. Together, these documents outline how the company manages its publicly traded securities and complies with exchange and SEC requirements.
On Stock Titan, investors can use AI-powered tools to review these filings, with real-time updates from EDGAR and summaries that explain the significance of items such as 8-K disclosures and Form 25 notices. This helps users quickly understand how The Hanover reports its financial condition, capital actions, and other material information within the regulatory framework for U.S. public companies.
An affiliate of THG filed a Rule 144 notice to sell 24,420 shares of common stock, with an aggregate market value of $4,369,097.03. The shares are expected to be sold on or around February 5, 2026 through Fidelity Brokerage Services LLC on the NYSE.
The filing reports that 35,583,964 shares of this class were outstanding. The shares to be sold were acquired mainly through restricted stock vesting in 2022, 2023, and 2025, and through the exercise of a stock option granted on February 23, 2016, with compensation and cash listed as the forms of payment.
The Hanover Insurance Group, Inc. furnished an 8-K to share that it has released its financial results for the quarter ended December 31, 2025. The company issued a press release on February 3, 2026, and also posted unaudited financial information in a Financial Supplement on its website.
The press release is included as Exhibit 99.1 and the unaudited Financial Supplement as Exhibit 99.2, with a cover page interactive data file provided as Exhibit 104.
The Hanover Insurance Group director Jane D. Carlin reported an internal share transfer rather than a new purchase or sale. On January 23, 2026, a total of 3,623 shares of Hanover common stock previously held indirectly under a deferral agreement were reclassified to direct ownership at a stated price of $0. The footnote explains this was a change of ownership from indirect to direct pursuant to the terms of a deferral agreement for stock previously awarded under the company’s 2014 Long-Term Incentive Plan. Following the transaction, Carlin held 3,623 shares directly and 2,306 shares indirectly under the deferral arrangement.
Hanover Insurance Group, Inc. reported that an executive vice president acquired additional common stock through a grant of restricted stock units. On 12/26/2025, the officer received 26.937 shares of common stock at a price of $0, recorded as an acquisition. After this transaction, the officer beneficially owned 25,704.879 shares of common stock in direct ownership. The new RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the grant date of the original RSUs.
Hanover Insurance Group, Inc. reported an insider equity grant for its President and CEO, who also serves as a director. On 12/26/2025, the executive acquired 134.535 shares of common stock at a price of $0 through restricted stock units under the company’s 2022 Long-Term Incentive Plan. These units were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the original RSU grant date.
Following this transaction, the executive beneficially owns 123,849.174 shares directly. The filing notes that this total does not include 14,454 shares held by the executive’s spouse.
Hanover Insurance Group, Inc. reported a routine equity award transaction for an executive officer. On 12/26/2025, the officer, who serves as Executive Vice President, received 11.844 shares of common stock in the form of restricted stock units (RSUs) at a price of $0 under the company’s 2022 Long-Term Incentive Plan.
The RSUs were granted as dividend equivalent rights tied to RSUs previously awarded under the same plan. These additional RSUs will vest on the third anniversary of the grant date of the original underlying RSUs. Following this transaction, the officer beneficially owns 3,523.34 shares of Hanover common stock in direct form.
Hanover Insurance Group executive reports small RSU grant
A Hanover Insurance Group, Inc. Executive Vice President reported receiving a grant of 11.747 shares of common stock in the form of restricted stock units (RSUs) on 12/26/2025. These RSUs were credited as dividend equivalent rights tied to RSUs previously granted under the company’s 2022 Long-Term Incentive Plan and will vest on the third anniversary of the original underlying RSU grant date. Following this transaction, the executive beneficially owns 2,289.372 shares of Hanover Insurance Group common stock directly. The RSUs were reported at a price of $0, consistent with a stock-based compensation award rather than an open-market purchase.
Hanover Insurance Group, Inc. reported that an Executive Vice President received additional common stock through a restricted stock unit (RSU) dividend accrual. On 12/26/2025, the officer acquired 12.247 shares of common stock at a price of $0, increasing direct beneficial ownership to 5,491.951 shares.
The new RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs. These RSUs will vest on the third anniversary of the grant date of the original underlying RSUs, aligning the executive’s compensation with long‑term shareholder interests.
Hanover Insurance Group, Inc. reported an equity award for an executive vice president through a Form 4 filing. On 12/26/2025, the officer acquired 31.585 shares of common stock at a price of $0, increasing their direct beneficial ownership to 39,173.879 shares. The transaction is coded as an acquisition related to the company’s long-term incentive program.
According to the explanation, this represents a grant of restricted stock units (RSUs) under the 2022 Long-Term Incentive Plan tied to dividend equivalent rights on previously granted RSUs. These RSUs will vest on the third anniversary of the grant date of the original underlying RSUs, meaning the added units follow the same vesting schedule as the original award.
Hanover Insurance Group, Inc. reported that an executive vice president received a small additional equity grant through its long-term incentive program. On 12/26/2025, the officer acquired 17.312 shares of common stock at a price of $0, increasing their direct beneficial ownership to 9,757.585 shares.
The new shares were granted as restricted stock units (RSUs) under Hanover’s 2022 Long-Term Incentive Plan. They arose from dividend equivalent rights tied to RSUs previously granted under the same plan, meaning the executive receives added RSUs in lieu of cash dividends on earlier awards. These RSUs will vest on the third anniversary of the original RSU grant date, aligning the executive’s interests with longer-term company performance.